Two established blood protein biomarkers for dementia — neurofilament light (NEFL or NfL) and glial fibrillary acidic protein (GFAP)(2–4) — were measured in the UKB Pharma Proteomics Project, which aims to provide insights into proteomic signatures for health and disease(5). This evidence concerns the gene NEFL and dementia.